Advanced Search

 

Study ID Status Title Patient Level Data
201570 Recruiting Randomized, Double-blind, Placebo Controlled Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses (Intravenous bolus) and constant intravenous infusion over 7 Days of GSK3335065 in Healthy Adult Subjects
201579 Withdrawn A two part Phase IIa Study, to Evaluate the Safety and Tolerability, Pharmacokinetics, Proof of Mechanism and Potential for Efficacy of an Anti-IL-7 Receptor-α Monoclonal Antibody (GSK2618960) in the Treatment of Primary Sjögren’s Syndrome
201580 Withdrawn A Phase II, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Proof of Concept Study with an Interim Futility Analysis of Epelsiban in Patients with Adenomyosis
201583 Completed A Phase I, Open-label, Randomized, Three-period Cross-over Study Evaluating the Effect of Cyclosporine on the Pharmacokinetics of Eltrombopag in Healthy Adult Subjects
201594 Completed An open-label study of the ease of use and correct use of placebo ELLIPTA dry powder inhaler in subjects with asthma
201595 Completed Post-hoc Analyses of Eosinophil Subgroups using Pooled Data from HZC102871 and HZC102970
201598 Recruiting An exploratory, retrospective laboratory evaluation of the humoral immune response in adults and children to the H1 HA stalk domain and other influenza A virus protein epitopes, after administration of GSK Biologicals’ pandemic influenza vaccines
201600 Not yet recruiting BOTOX Drug Use Investigation (Strabismus)
201604 Completed Patient Satisfaction and Symptom Management Goal: Survey of Japanese adult patients with bronchial asthma receiving inhaled corticosteroid-containing medications
201606 Not yet recruiting Long-term immunogenicity of the HIV gp120-NefTat/AS01B vaccine (GSK SB732461)
201608 Completed PGx7592: Evaluation of the Effect of BIM Germline Variants on Pazopanib Efficacy in Patients with Cancer
201614 Completed An Open Label, Single-arm Study Evaluating a New Thermostable Formulation of FLOLAN™ in Japanese Subjects with Pulmonary Arterial Hypertension (PAH)
201624 Completed PGx7571: Pharmacogenetic Evaluation of FCGR Variation in patients treated with ofatumumab in study OMB115991
201625 Completed PGx7602: Pharmacogenetic Evaluation of FCGR Variation in patients treated with ofatumumab in study OMB110927
201627 Completed PGx7604: Pharmacogenetic Evaluation of FCGR Variation in patients treated with ofatumumab in study OMB114242
201630 Recruiting Long term hepatitis A virus (HAV) antibody persistence in children vaccinated with 1 dose and those vaccinated with 2 doses of Havrix® in Panama
201634 Completed PGx7575: Pharmacogenetic Evaluation of FCGR Variation in patients treated with ofatumumab in study OMB110928
201636 Active, not recruiting A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Rilpivirine From Current INI-, NNRTI-, or PI-based Antiretroviral Regimen in HIV-1-Infected Adults who are Virologically Suppressed
201637 Active, not recruiting A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Rilpivirine From Current INI-, NNRTI-, or PI-based Antiretroviral Regimen in HIV-1-Infected Adults who are Virologically Suppressed (SWORD-2)
201641 Active, Not Recruiting HO-14-14607 - OBSERVATIONAL STUDY TO EXPLORE THE SAFETY, COSTS AND HEALTH CARE RESOURCE UTILIZATION, ASSOCIATED WITH FIRST LINE ARZERRA (OFATUMUMAB) OR GAZYVA (OBINUTUZUMAB) THERAPIES IN PATIENTS WITH UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN REAL WORLD SETTING
201657 Completed Meta-analysis of clinical efficacy studies of licensed Rheumatoid Arthritis (RA) treatments
201659 Terminated An Adaptive Design Open Label Pilot Study in Rheumatoid Arthritis Patients to Assess Inflammation Using Molecular Imaging Techniques
201661 Completed Skin Residency Study of Topically Applied GSK2894512 Cream in Healthy Volunteers
201663 Recruiting Immunogenicity, reactogenicity and safety study of Pediarix®, Hiberix® and Prevenar 13® co-administered with two different formulations of GSK Biologicals’ HRV vaccine (444563) in healthy infants 6-12 weeks of age
201664 Suspended A three-part open-label, non-randomised, dose-escalation study to investigate the safety and tolerability of GSK3039294 administered as a single dose to healthy volunteers, and as repeat dose to healthy volunteers and patients with systemic amyloidosis

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.